Home > Boards > US Listed > Biotechs > Aravive - Oncology/Biotech Company (ARAV)

Insane fun this AM to over $29.00. Crazy

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
cjstocksup Member Profile
Member Level 
Followed By 3,471
Posts 229,198
Boards Moderated 0
Alias Born 07/30/07
160x600 placeholder
Aravive To Present at The 2020 RBC Capital Markets Global Healthcare Conference GlobeNewswire Inc. - 5/12/2020 8:00:10 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/6/2020 4:19:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2020 4:12:05 PM
Aravive Reports First Quarter 2020 Financial Results and Provides Recent Corporate Updates GlobeNewswire Inc. - 5/6/2020 4:05:10 PM
Aravive and WuXi Biologics Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies Targeting Cancer... GlobeNewswire Inc. - 4/30/2020 8:00:10 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 4/16/2020 6:02:41 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/10/2020 4:30:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/9/2020 4:44:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/9/2020 4:11:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/9/2020 4:08:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/9/2020 4:06:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/9/2020 4:06:16 PM
Aravive Announces Board Composition and Executive Management Transitions GlobeNewswire Inc. - 4/9/2020 7:08:32 AM
Aravive Announces AVB-500 Improves Anti-Tumor Effects when Combined with Anti-Angiogenic Bevacizumab or PARP Inhibitor Olapar... GlobeNewswire Inc. - 3/30/2020 8:00:10 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 3/27/2020 8:39:09 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/27/2020 8:13:32 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/27/2020 8:07:16 AM
Aravive Reports Fourth Quarter and Twelve Months Ended December 31, 2019 Financial Results and Provides Recent Corporate Upda... GlobeNewswire Inc. - 3/27/2020 8:00:10 AM
Aravive Announces Initiation of Investigator-Sponsored Phase 1/2 Study of AVB-500 in Combination with Avelumab in Patients wi... GlobeNewswire Inc. - 3/24/2020 8:00:10 AM
Aravive To Present at The Cowen and Company 40th Annual Health Care Conference GlobeNewswire Inc. - 2/25/2020 4:07:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/18/2020 8:12:10 AM
Aravive Announces Dose Escalation of AVB-500 in Recurrent Platinum Resistant Ovarian Cancer Phase 1b Trial GlobeNewswire Inc. - 2/18/2020 8:00:10 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2020 6:08:35 AM
Aravive Receives IND Clearance for Phase 1b/Phase 2 Clinical Trial of AVB-500 in Patients with Clear Cell Renal Cell Carcinom... GlobeNewswire Inc. - 1/13/2020 8:00:10 AM
Aravive Announces Management Changes GlobeNewswire Inc. - 1/9/2020 4:05:10 PM
cjstocksup Member Level  Wednesday, 11/20/19 09:25:17 AM
Re: Awl416 post# 3
Post # of 47 
Insane fun this AM to over $29.00. Crazy trading here now before the open on the fall. It will be an interesting day and it has been easy to make money so far.
ARAV

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist